May 2007
Volume 48, Issue 13
ARVO Annual Meeting Abstract  |   May 2007
A Bleb-Free Approach to Reduction of Iop in Treatment of Glaucoma
Author Affiliations & Notes
  • R. J. Noecker
    Ophthalmology, Univ of Pittsburgh Eye & Ear Inst, Pittsburgh, Pennsylvania
  • J. S. Schuman
    Ophthalmology, Univ of Pittsburgh Eye & Ear Inst, Pittsburgh, Pennsylvania
  • Footnotes
    Commercial Relationships R.J. Noecker, None; J.S. Schuman, None.
  • Footnotes
    Support None.
Investigative Ophthalmology & Visual Science May 2007, Vol.48, 5672. doi:
  • Views
  • Share
  • Tools
    • Alerts
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      R. J. Noecker, J. S. Schuman; A Bleb-Free Approach to Reduction of Iop in Treatment of Glaucoma. Invest. Ophthalmol. Vis. Sci. 2007;48(13):5672.

      Download citation file:

      © ARVO (1962-2015); The Authors (2016-present)

  • Supplements

Purpose:: To evaluate the efficacy of a novel, gold-micro shunt in reducing intraocular pressure for the treatment of glaucoma without creation of a bleb. The micro shunt is designed to facilitate aqueous flow from the anterior chamber into the suprachoroidal space by utilizing the eye’s natural pressure gradient between the AC and the SCS.

Methods:: The GMS was implanted through a micro, partial-depth scleral incision with one end in the suprachoroidal space and the other in the anterior chamber. In a 2-site, prospective clinical study, 76 eyes were implanted with the GMS and followed for two years. Patients were monitored for IOP, reduction in number of pressure-lowering medications and complications.

Results:: The mean pre-operative IOP was 27.7 ± 5.9 mm Hg. The mean post-operative IOP at 1-year was 19.7 ±7.9 mm Hg (50 eyes) and 19.7 ±3.3 mm Hg at the 2-year follow-up (18 eyes). No serious complications were observed during the surgeries. No migration of the implant or corneal decompensation was observed in the first 6 post-operative months. The most common complication of this procedure was transient hyphema, with no cases of long-term hypotony.

Conclusions:: The design of the GMS is intended to facilitate aqueous flow, thereby reducing IOP, without creation of a bleb as typically seen with traditional filtration surgery. Additional safety and efficacy data continues to be collected to verify early findings.The biocompatibility of a gold-micro shunt offers an option to glaucoma surgeons who have had to frequently accept significant complications with other drainage devices in order to reduce IOP in glaucoma patients. The initial results demonstrate that IOP reduction can be achieved without the creation of a filtration bleb, thus eliminating numerous post-operative management issues.

Clinical Trial:: G050140

Keywords: intraocular pressure • outflow: trabecular meshwork • clinical (human) or epidemiologic studies: outcomes/complications 

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.